Sprinter Health

First partner to exceptional teams everywhere.

We back ambitious founders who actively seek to change the status quo.

Backs bold entrepreneurs building the future through technology.

Launched as Google Ventures in 2009, GV originated as an independent venture capital firm for innovative founders. With Alphabet as their sole limited partner, they focus all our energy on meeting and supporting founders at the earliest stages of company-building.

Amy Saper joined Accel in 2019. Previously, Amy spent time at Stripe. As the second marketing hire, she helped build and grow the Product Marketing team, leading global product launches across Stripe’s suite of products. Prior to Stripe, Amy launched products and countries at Twitter, as she helped the company scale from a pre-revenue startup to a public company over the course of four years.

Early investor in market-leading companies like Stripe, Livongo (acquired by Teladoc in an $18.5B merger, the largest in digital health history to-date), Samsara (NYSE: IOT), Snap (NYSE: SNAP), Fundbox, Grammarly, Gusto, Applied Intuition, and Anduril Author of Intended Consequences: How to Build Market-Leading Companies with Responsible Innovation, UnHealthcare: A Manifesto for Health Assurance, and Unscaled, Five degrees from MIT: M.Eng. EECS, S.M. Operations Research, S.B. Biology, S.B. Mathematics, and S.B. EECS

Senator Bill Frist is a leading authority on healthcare and former U.S. Senate Majority Leader. As Co-founder and Partner at FCV, he resides on the fund’s Investment Committee and is responsible for acquisition, divestitures and providing unique value to the fund’s partnerships. Senator Frist served two terms as a United States Senator representing Tennessee, serving as Majority Leader from 2003 until his retirement in 2007. His leadership was instrumental in the passage of the 2003 Medicare Modernization Act and the historic PEPFAR legislation that provided life-saving treatment globally to over 20 million people. Prior to the Senate, he founded the Vanderbilt Multi-Organ Transplant Center and has performed more than 150 heart and lung transplant procedures.

Julie leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access.